Pfizer says it’s developing a third COVID-19 vaccine dose to further boost immunity, fend off variants

0
233

Early information from Pfizer’s booster research suggests folks’s antibody ranges leap five- to 10-fold after a 3rd dose, in comparison with their second dose months earlier.